Product NewsDrug discovery > Clinical Development BioAlliance Pharma announces preliminary results of its Doxorubicin Transdrug® Phase I/II clinical trial for primary liver cancer
Product NewsDrug discovery > Lead Discovery BioAlliance Pharma annonce les résultats préliminaires de l’essai clinique de Phase I/II de doxorubicine Transdrug® pour le traitement du cancer primitif du foie
Product NewsDrug discovery > Lead Discovery US Phase III study of Avastin in advanced pancreatic cancer does not meet primary endpoint
Product NewsDrug discovery > Clinical Development ClinPhone Launches Ground-Breaking Drug Accountability Solution For Clinical Trials
Product NewsDrug discovery > Lead Discovery Reprise prochaine du recrutement dans l'étude internationale de phase III AVANT sur le traitement adjuvant postopératoire du cancer du côlon
Product NewsDrug discovery > Lead Discovery La chimiothérapie orale Xeloda s'avère efficace contre le cancer de l'estomac
Product NewsClinical Diagnostics Colder Products Company Introduces Subminiature Couplings with IdentiQuik® RFID Technology
Product NewsDrug discovery > Clinical Development Oxford Biomedica reports new encouraging phase II results with TroVax® and progress in the development plan
Product NewsDrug discovery > Clinical Development TopoTarget and CuraGen Initiate NCI-sponsored Phase II Clinical Trial of PXD101 for Acute Myelogenous Leukemia
Product NewsClinical Diagnostics AXIS-SHIELD ANNOUNCES LAUNCH OF FIRST ASSAY UNDER AXSYM® XTRA PROGRAMME – PART OF PROJECT TO EXPAND AXSYM’S BROAD TEST MENU
Product NewsDrug discovery > Lead Discovery Study in the journal vaccine reports positive results of DNA-based Flu vaccine in Humans
Product NewsDrug discovery > Lead Discovery Avastin filed with FDA in US for treatment of women with advanced breast cancer
Product NewsDrug discovery > Clinical Development CeNeS announces the publication of an important independent review of its lead product, M6G
Product NewsLife Sciences Guava Technologies Announces FDA 510(k) Clearance of Guava® EZCD4 System for CD4 Monitoring
Product NewsDrug discovery > Clinical Development Oxford Biomedica commences phase II trial of TroVax® in prostate cancer
Product NewsLab Informatics Guava Technologies Announces FDA 510(k) Clearance of Guava® EZCD4 System for CD4 Monitoring
Product NewsLife Sciences Salisbury District Hospital goes live with Acolyte Biomedica’s BacLite®flex system for rapid MRSA screening
